Results 31 to 40 of about 65,470 (161)

Resultado del tratamiento rehabilitador en pacientes con esclerosis múltiple [PDF]

, 2020
Introduction: multiple sclerosis is a demyelinating, degenerative, chronic and progressive disease of the central nervous system that constitutes one of the causes of neurological disability in young adults.
Fraga Ramírez, Osvaldo, Avello Olivert, María Eneida, Navarro Jiménez, Loraine, Herrera Broche, Maikel, Blanco Ramos, Claristel, Vásquez Gómez, Lázaro Aurelio   +5 more
core   +1 more source

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis

Frontiers in Immunology, 2019
Gut microbiota dysbiosis has been implicated in MS and other immune diseases, although it remains unclear how manipulating the gut microbiota may affect the disease course.
Leyre Mestre, Leyre Mestre, Francisco Javier Carrillo-Salinas, Miriam Mecha, Miriam Mecha, Ana Feliú, Ana Feliú, Carmen Espejo, Carmen Espejo, Carmen Espejo, José Carlos Álvarez-Cermeño, José Carlos Álvarez-Cermeño, Luisa María Villar, Luisa María Villar, Carmen Guaza, Carmen Guaza   +15 more
doaj   +1 more source

Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls

Cells, 2021
Although the etiology of multiple sclerosis (MS) is still unknown, it is commonly accepted that environmental factors could contribute to the disease.
Maria Inmaculada Dominguez-Mozo, Silvia Perez-Perez, Noelia Villarrubia, Lucienne Costa-Frossard, Jose Ignacio Fernandez-Velasco, Isabel Ortega-Madueño, Maria Angel Garcia-Martinez, Estefania Garcia-Calvo, Hector Estevez, Jose Luis Luque Garcia, Maria Josefa Torrejon, Rafael Arroyo, Luisa Maria Villar, Roberto Alvarez-Lafuente   +13 more
doaj   +1 more source

A guide to treating gait impairment with prolonged-release fampridine (Fampyra®) in patients with multiple sclerosis

Neurología (English Edition), 2018
Introduction: Gait impairment, a frequent sign in multiple sclerosis (MS), places a major burden on patients since it results in progressive loss of personal and social autonomy, along with work productivity. This guide aims to provide recommendations on
L. Ramió-Torrentà, J.C. Álvarez-Cermeño, R. Arroyo, B. Casanova-Estruch, O. Fernández, J.A. García-Merino, M.A. Hernández, G. Izquierdo, S. Martínez-Yélamos, J. Meca, E. Moral, J. Olascoaga, J.M. Prieto, A. Saiz   +13 more
doaj   +1 more source

RECENT-DEM: percepción de las personas recién diagnosticadas de esclerosis múltiple y sus familiares sobre sus necesidades de atención sociosanitaria. Informe de resultados [PDF]

, 2021
El presente informe recoge los resultados de una investigación iniciada en 2019 por Esclerosis Múltiple España con la que se pretende conocer todo lo que rodea actualmente el diagnóstico de esa enfermedad en España, así como los principales recursos ...
Nephila Health Partnership, S.L.
core  

Guía de tratamiento del deterioro de la marcha con fampridina de liberación prolongada (Fampyra®) en pacientes con esclerosis múltiple

Neurología, 2018
Resumen: Introducción: La alteración de la marcha es frecuente en la esclerosis múltiple (EM) y tiene un gran impacto negativo en los pacientes pues conlleva a la pérdida progresiva de autonomía personal y social, y de productividad laboral.
L. Ramió-Torrentà, J.C. Álvarez-Cermeño, R. Arroyo, B. Casanova-Estruch, O. Fernández, J.A. García-Merino, M.A. Hernández, G. Izquierdo, S. Martínez-Yélamos, J. Meca, E. Moral, J. Olascoaga, J.M. Prieto, A. Saiz   +13 more
doaj   +1 more source

Empowerment and proactivity against multiple sclerosis [PDF]

, 2013
Este artículo describe el trabajo de Esclerosis Múltiple España en materia de empoderamiento y proactividad de las personas que padecen esta enfermedad ...
Esclerosis Múltiple España
core   +1 more source

Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies

Vaccines, 2023
Background: This study aimed to evaluate short- and long-term humoral and T-cell-specific immune responses to SARS-CoV-2 vaccines in patients with multiple sclerosis (MS) treated with different disease-modifying therapies (DMTs).
Susana Sainz de la Maza, Paulette Esperanza Walo-Delgado, Mario Rodríguez-Domínguez, Enric Monreal, Alexander Rodero-Romero, Juan Luis Chico-García, Roberto Pariente, Fernando Rodríguez-Jorge, Rubén Ballester-González, Noelia Villarrubia, Beatriz Romero-Hernández, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar   +13 more
doaj   +1 more source

Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival

Brain Pathology, Volume 36, Issue 5, September 2026.
Untargeted multiomic profiling of cerebrospinal fluid reveals that proteomic, but not lipidomic, signatures robustly distinguish ALS patients from controls and stratify individuals by survival, highlighting marked molecular differences between short survival and long survival disease.
Sergio Roca‐Pereira, Yaiza López‐Sampere, Pol Mengod‐Soler, Mario Peña‐Fonteboa, Carla Marco, Alejandro Caravaca‐Puchades, Raúl Domínguez, Juan Francisco Vázquez‐Costa, Enrique Santamaría, Joaquín Fernández‐Irigoyen, María J. Colomina, Isabel León Moreno, Antonio Martínez Yélamos, Sergio Martínez Yélamos, Gabriel Santpere, Elia Obis, Manuel Portero‐Otín, Gerard Piñol‐Ripoll, Mónica Povedano, Pol Andrés‐Benito   +19 more
wiley   +1 more source

Recommendations for using and interpreting magnetic resonance imaging in multiple sclerosis

Neurología (English Edition), 2010
Objective: To establish recommendations for using and interpreting magnetic resonance imaging (MRI) results in the diagnosis and follow up of multiple sclerosis (MS).
A. Rovira, M. Tintoré, J.C. Álvarez-Cermeño, G. Izquierdo, J.M. Prieto   +4 more
doaj   +1 more source